Shelley H Liu, PhD
- ASSISTANT PROFESSOR | Population Health Science and Policy
Research Topics:
Biostatistics, Environmental Health, Epidemiology, Pediatrics, Psychiatry, Public HealthShelley H. Liu is an Assistant Professor in the Center for Biostatistics, Department of Population Health Science and Policy. Dr. Liu’s primary research interests are in longitudinal data analysis, Bayesian analysis, latent class analysis, environmental epidemiology and children’s health. Dr. Liu received her BA from Northwestern University in 2011, and her PhD in Biostatistics from Harvard University in 2016. During her doctoral training, she developed statistical methods for environmental health research. These projects included developing methods for estimating the health effects associated with exposure mixtures, and identifying critical time windows of vulnerability to exposures. For her dissertation research, she received a Distinguished Student Paper Award from the International Biometric Society - Eastern North America Region. She also received two National Science Foundation EAPSI awards to conduct research in Australia and China. Through these awards, she developed computationally efficient methods to analyze large longitudinal cohort data.
Education
BA, Northwestern University
PhD, Harvard University
-
2017
Distinguished Student Paper Award -
2017
Student Paper Travel Award -
2017
Travel Award -
2017
New Researcher Best Abstract Award -
2016
East Asia and Pacific Summer Institutes – China Fellowship -
2015
East Asia and Pacific Summer Institutes – Australia Fellowship -
2014
Rose Traveling Fellowship in Chronic Disease Epidemiology and Biostatistics
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Liu did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.